Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis

被引:8
|
作者
Mitsuteru Kitade [1 ]
Hitoshi Yoshiji [1 ]
Ryuichi Noguchi [1 ]
Yasuhide Ikenaka [1 ]
Kosuke Kaji [1 ]
Yusaku Shirai [1 ]
Masaharu Yamazaki [1 ]
Masahito Uemura [1 ]
Junichi Yamao [1 ]
Masao Fujimoto [1 ]
Akira Mitoro [1 ]
Masahisa Toyohara [1 ]
Masayoshi Sawai [1 ]
Motoyuki Yoshida [1 ]
Chie Morioka [1 ]
Tatsuhiro Tsujimoto [1 ]
Hideto Kawaratani [1 ]
Hiroshi Fukui [1 ]
机构
[1] Third Department of Internal Medicine, Nara Medical University
关键词
Angiogenesis; Cytokeratin-18; Fatty liver; Insulin resistance; Non-alcoholic steatohepatitis; Liver fi brosis;
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
1002 ; 100201 ;
摘要
AIM: To elucidate the possible crosstalk between angiogenesis, cytokeratin-18 (CK-18), and insulin resistance (IR) especially in patients with non-alcoholic steatohepatitis (NASH).METHODS: Twenty-eight patients with NASH and 11 with simple fatty liver disease (FL) were enrolled in this study and underwent clinicopathological examination. The measures of angiogenesis, CK-18, and IR employed were CD34-immunopositive vessels, CK-18immunopositive cells, and homeostasis model assessment of IR (HOMA-IR), respectively. The correlations of these factors with NASH were elucidated.RESULTS: Significant development of hepatic neovascularization was observed only in NASH, whereas almost no neovascularization could be observed in FL and healthy liver. The degree of angiogenesis was almost parallel to liver fibrosis development, and both parameters were positively correlated. Similarly, CK-18expression and HOMA-R were signifi cantly increased in NASH as compared with FL and healthy liver. Furthermore, CK-18 and HOMA-IR were also positively correlated with the degree of neovascularization. CONCLUSION: These results indicate that the crosstalk between angiogenesis, CK-18, and IR may play an important role in the onset and progression of NASH.
引用
收藏
页码:5193 / 5199
页数:7
相关论文
共 50 条
  • [1] Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis
    Kitade, Mitsuteru
    Yoshiji, Hitoshi
    Noguchi, Ryuichi
    Ikenaka, Yasuhide
    Kaji, Kosuke
    Shirai, Yusaku
    Yamazaki, Masaharu
    Uemura, Masahito
    Yamao, Junichi
    Fujimoto, Masao
    Mitoro, Akira
    Toyohara, Masahisa
    Sawai, Masayoshi
    Yoshida, Motoyuki
    Morioka, Chie
    Tsujimoto, Tatsuhiro
    Kawaratani, Hideto
    Fukui, Hiroshi
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (41) : 5193 - 5199
  • [2] Is the measurement of serum cytokeratin-18 useful for diagnosis or screening non-alcoholic steatohepatitis?
    Yoneda, Masashi
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (08) : 827 - 828
  • [3] Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis
    Chen, Jing
    Zhu, Yueyong
    Zheng, Qi
    Jiang, Jiaji
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (08) : 854 - 862
  • [4] Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease
    Kawanaka, Miwa
    Nishino, Ken
    Nakamura, Jun
    Urata, Noriyo
    Oka, Takahito
    Goto, Daisuke
    Suehiro, Mitsuhiko
    Kawamoto, Hirofumi
    Yamada, Gotaro
    [J]. ANNALS OF HEPATOLOGY, 2015, 14 (06) : 837 - 844
  • [5] NON-INVASIVE DIAGNOSIS OF NON-ALCOHOLIC STEATOHEPATITIS BY COMBINED CYTOKERATIN-18 APOPTOTIC FRAGMENT AND ELASTOMETRY
    Carenzi, S.
    Rosso, C.
    Mezzabotta, L.
    Caviglia, G. P.
    Salamone, F.
    Rizzetto, M.
    Smedile, A.
    Abate, M. L.
    Bugianesi, E.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S505 - S505
  • [6] Insulin resistance in non-alcoholic steatohepatitis
    Cömert, B
    Mas, MR
    Erdem, H
    Dinc, A
    Saglamkaya, U
    Cigerim, M
    Kuzhan, O
    Unal, T
    Kocabalkan, F
    [J]. DIGESTIVE AND LIVER DISEASE, 2001, 33 (04) : 353 - 358
  • [7] Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis
    Tankurt, E
    Biberoglu, S
    Ellidokuz, E
    Hekimsoy, Z
    Akpinar, H
    Çömlekçi, A
    Okan, A
    Sagol, Ö
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 (05) : 963 - 963
  • [8] Usefulness of Monitoring Serum Cytokeratin-18 levels for Evaluating Long-term Prognosis in Patients with Non-Alcoholic Steatohepatitis/Non-Alcoholic Fatty Liver Disease
    Kawanaka, Miwa
    Nishino, Ken
    Nakamura, Jun
    Oka, Takahito
    Urata, Noriyo
    Goto, Daisuke
    Suehiro, Mitsuhiko
    Kawamoto, Hirofumi
    Yamada, Gotaro
    [J]. HEPATOLOGY, 2013, 58 : 474A - 474A
  • [9] Features of the connective tissue metabolism, the content of adipokines and cytokeratin-18 in patients with non-alcoholic steatohepatitis combined with osteoarthritis and obesity
    Khukhlina, O. S.
    Liakhovych, O. D.
    Kaniovska, L., V
    Kaushanska, O., V
    Shuper, V. O.
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2019, 21 (04) : 444 - 448
  • [10] Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
    Cusi, Kenneth
    [J]. CLINICS IN LIVER DISEASE, 2009, 13 (04) : 545 - +